Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Loading metrics

Open Access

Correction

Correction: Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer

Tarun Mehra,
Judith E. Lupatsch,
Thibaud Koessler,
Konstantin Dedes,
Alexander Reinhard Siebenhüner,
Roger von Moos,
Andreas Wicki,
Matthias E. Schwenkglenks

Correction: Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer

Tarun Mehra,
Judith E. Lupatsch,
Thibaud Koessler,
Konstantin Dedes,
Alexander Reinhard Siebenhüner,
Roger von Moos,
Andreas Wicki,
Matthias E. Schwenkglenks

x

Published: December 12, 2024
https://doi.org/10.1371/journal.pone.0315976

Reader Comments (0)

Post a new comment on this article